| JYHB2300131 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2023-02-21 | | AstraZeneca AB | | | view |
| JXHL2300320 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-12-22 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| CYHS2101144 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(4) | Generic Drug | 2021-05-12 | | Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd | | | view |
| JXHL2400257 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2024-10-25 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXHL2101260 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-11-26 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXHS2300086 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-09-21 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| CYHS2101145 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(4) | Generic Drug | 2021-05-12 | | Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd | | | view |
| JXHL1900320 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-11-22 | | AstraZeneca AB | In Review | 2019-11-21 | view |
| JXHS2400041 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2024-06-21 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXHB2200039 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2022-03-24 | | AstraZeneca AB | | | view |
| JXHL1800076 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2018-07-09 | | AstraZeneca AB | Certificate Issued | 2018-09-04 | view |
| JXHL2300322 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-12-22 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JTH2100638 | 奥希替尼薄膜衣片 | osimertinib mesylate | Tablet | Chemical Drugs | Disposable Import Drug Application | 2021-09-03 | | AstraZeneca AB;Hutchison MediPharma Co Ltd;Astrazeneca Uk Ltd | | | view |
| JYHB2400369 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2024-07-17 | | AstraZeneca AB | | | view |
| JXHL2101219 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-10-28 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JYHB2300486 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2023-08-29 | | AstraZeneca AB | | | view |
| JXHL2101261 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-11-26 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JYHB2400004 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2024-01-04 | | AstraZeneca AB | | | view |
| JYHZ2100528 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | License Renew | 2021-04-23 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JTH2300035 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Disposable Import Drug Application | 2023-02-11 | | AstraZeneca AB;Hutchison MediPharma Co Ltd | | | view |
